Geode Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.64M | Buy |
|
|||||
|
2025
Q1 | $9.4M | Buy |
|
|||||
|
2024
Q4 | $14.8M | Buy |
|
|||||
|
2024
Q3 | $20.2M | Buy |
|
|||||
|
2024
Q2 | $17M | Buy |
|
|||||
|
2024
Q1 | $11.5M | Buy |
|
|||||
|
2023
Q4 | $6.68M | Buy |
|
|||||
|
2023
Q3 | $5.35M | Buy |
|
|||||
|
2023
Q2 | $5.51M | Sell |
|
|||||
|
2023
Q1 | $5.5M | Sell |
|
|||||
|
2022
Q4 | $5.88M | Buy |
|
|||||
|
2022
Q3 | $6.94M | Buy |
|
|||||
|
2022
Q2 | $6.47M | Buy |
|
|||||
|
2022
Q1 | $4.63M | Buy |
|
|||||
|
2021
Q4 | $6.66M | Buy |
|
|||||
|
2021
Q3 | $9.51M | Buy |
|
|||||
|
2021
Q2 | $6M | Buy |
|
|||||
|
2021
Q1 | $9.18M | Buy |
|